Anti-phospho-Sufu, Polyclonal
Invented at University of Oxford
Anti-Sufu, Polyclonal
Invented at University of Oxford
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 153541 |
| Applications | WB |
| Antigen/Gene or Protein Targets | Sufu (UniProt ID: Q9UMX1) |
| Synonyms | Suppressor of fused homolog, SUFUH |
| Reactivity | Human and Mouse |
| Relevance |
Sufu is a negative regulator in the hedgehog signaling pathway which directs cell proliferation and patterning during embryogenesis. Sufu down-regulates GLI1- and GLI2-mediated transactivation of target genes and is part of a corepressor complex that acts on DNA-bound GLI1. Required for normal embryonic development. Sufu is ubiquitous in adult tissues. Heterozygous loss of Sufu, in conjunction with the loss of p53, leads to the development of medulloblastoma and rhabdomyosarcoma. Somatic Sufu mutations have been identified in multiple other malignancies, including prostate cancer. |
| Host | Rabbit |
| Immunogen | Sufu peptide: Hu #347~360: CLESDSSTAIIPHEL (non-phosphorylated) |
| Concentration | 2mg/ml |
| Method of Purification | Affinity purified |
| Notes | Dilution used for western blot: 1:500 |
| Research Area | Cancer, Developmental Biology, Gene Expression |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
